Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
S. R. Davis, S. Taylor, C. Hemachandra, K. Magraith, P. R. Ebeling, F. Jane & R. M. Islam. (2023) The 2023 Practitioner’s Toolkit for Managing Menopause. Climacteric 26:6, pages 517-536.
Read now
Read now
C. C. Zouboulis, U. Blume-Peytavi, M. Kosmadaki, E. Roó, D. Vexiau-Robert, D. Kerob & S. R. Goldstein. (2022) Skin, hair and beyond: the impact of menopause. Climacteric 25:5, pages 434-442.
Read now
Read now
J. H. Pickar, D. F. Archer, S. R. Goldstein, R. Kagan, B. Bernick & S. Mirkin. (2020) Uterine bleeding with hormone therapies in menopausal women: a systematic review. Climacteric 23:6, pages 550-558.
Read now
Read now
Maria P. Yavropoulou, Polyzois Makras & Athanasios D. Anastasilakis. (2019) Bazedoxifene for the treatment of osteoporosis. Expert Opinion on Pharmacotherapy 20:10, pages 1201-1210.
Read now
Read now
Risa Kagan, Paula Abreu & Emma Andrews. (2018) Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo. Postgraduate Medicine 130:8, pages 687-693.
Read now
Read now
Placido Llaneza, Joaquim Calaf, Ana Rosa Jurado, Nicolas Mendoza, Borja Otero, Francisco Quereda, Rafael Sánchez-Borrego & Daniel Lubian. (2018) What do TSECs provide in the menopausal hormone therapy?. Gynecological Endocrinology 34:10, pages 826-832.
Read now
Read now
Sharon J. Parish & John A. Gillespie. (2017) The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. Postgraduate Medicine 129:3, pages 340-351.
Read now
Read now
Risa Kagan, Steven R Goldstein, James H Pickar & Barry S Komm. (2016) Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene. Therapeutics and Clinical Risk Management 12, pages 549-562.
Read now
Read now
P. Hadji, K. A. Ryan, C.-R. Yu, S. Mirkin & Barry S. Komm. (2016) CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis. Climacteric 19:5, pages 482-487.
Read now
Read now
S. Palacios, L. Arias, J. Lavenberg, K. Pan, S. Mirkin & B. S. Komm. (2016) Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population. Climacteric 19:3, pages 261-267.
Read now
Read now
B. S. Komm, J. R. Thompson & S. Mirkin. (2015) Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials. Climacteric 18:4, pages 503-511.
Read now
Read now
Andrea R Genazzani, Barry S Komm & James H Pickar. (2015) Emerging hormonal treatments for menopausal symptoms. Expert Opinion on Emerging Drugs 20:1, pages 31-46.
Read now
Read now
F. M. Jane & S. R. Davis. (2014) A Practitioner's Toolkit for Managing the Menopause. Climacteric 17:5, pages 564-579.
Read now
Read now
Maryam Sharifi & E Michael Lewiecki. (2014) Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy. Expert Review of Clinical Pharmacology 7:3, pages 281-291.
Read now
Read now
J. V. Pinkerton, B. S. Komm & S. Mirkin. (2013) Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model. Climacteric 16:6, pages 618-628.
Read now
Read now
Maurizio Rossini, Stefano Lello, Ignazio Sblendorio, Ombretta Viapiana, Elena Fracassi, Silvano Adami & Davide Gatti. (2013) Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture. Drug Design, Development and Therapy 7, pages 601-610.
Read now
Read now
Sri Harsha Tella & John Christopher Gallagher. (2013)
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause. Expert Opinion on Pharmacotherapy 14:17, pages 2407-2420.
Read now
Read now
Articles from other publishers (46)
Susan R. Davis, JoAnn Pinkerton, Nanette Santoro & Tommaso Simoncini. (2023) Menopause—Biology, consequences, supportive care, and therapeutic options. Cell 186:19, pages 4038-4058.
Crossref
Crossref
V.O. Benyuk, V.V. Kurochka, V.F. Oleshko & A.A. Momot. (2022) Modern integrated approach in the treatment of atrophic vaginitis in women of menopausal age. Reproductive health of woman:5, pages 51-56.
Crossref
Crossref
M. S. LeBoff, S. L. Greenspan, K. L. Insogna, E. M. Lewiecki, K. G. Saag, A. J. Singer & E. S. Siris. (2022) The clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International 33:10, pages 2049-2102.
Crossref
Crossref
Patricia Geraghty. 2022. Each Woman’s Menopause: An Evidence Based Resource. Each Woman’s Menopause: An Evidence Based Resource
121
143
.
Nese Yuksel, Debra Evaniuk, Lina Huang, Unjali Malhotra, Jennifer Blake, Wendy Wolfman & Michel Fortier. (2021) Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie. Journal of Obstetrics and Gynaecology Canada 43:10, pages 1205-1223.e1.
Crossref
Crossref
Nese Yuksel, Debra Evaniuk, Lina Huang, Unjali Malhotra, Jennifer Blake, Wendy Wolfman & Michel Fortier. (2021) Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle. Journal of Obstetrics and Gynaecology Canada 43:10, pages 1188-1204.e1.
Crossref
Crossref
Bo Mi Kim, Sung Eun Kim, Dong-Yun Lee & DooSeok Choi. (2021) Effect of Tissue-Selective Estrogen Complex on Hip Structural Geometry in Postmenopausal Women: A 12-Month Study. Frontiers in Endocrinology 12.
Crossref
Crossref
Ya.Z. Zaidieva & V.D. Kazantseva. (2021) Comparative analysis of the prevalence of abnormal uterine bleeding in postmenopausal women against the background of various menopausal hormone therapy (systematic review). Rossiiskii vestnik akushera-ginekologa 21:6, pages 51.
Crossref
Crossref
Sasha De Jesus, Eugenia Gianos, Stephanie Trentacoste McNally, Dawn C. Scantlebury & Stacey E. Rosen. 2021. Sex Differences in Cardiac Diseases. Sex Differences in Cardiac Diseases
539
565
.
О. О. Єфіменко. (2020) Menopause. A problem that is not out of date. Specialist comment and updated data from the National Consensus on the Management of Patients in Menopause. REPRODUCTIVE ENDOCRINOLOGY:51, pages 72-88.
Crossref
Crossref
Dong-Yun Lee. (2020) Tissue-Selective Estrogen Complex and Breast. Journal of Menopausal Medicine 26:2, pages 99.
Crossref
Crossref
Sa Ra LeeMoon Kyoung ChoYeon Jean ChoSungwook ChunSeung-Hwa HongKyu Ri HwangGyun-Ho JeonJong Kil JooSeul Ki KimDong Ock LeeDong-Yun LeeEun Sil LeeJae Yen SongKyong Wook YiBo Hyon YunJung-Ho ShinHee Dong Chae & Tak Kim. (2020) The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine 26:2, pages 69.
Crossref
Crossref
L. Vignozzi, N. Malavolta, P. Villa, G. Mangili, S. Migliaccio & S. Lello. (2018) Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO. Journal of Endocrinological Investigation 42:5, pages 609-618.
Crossref
Crossref
Sung Eun Kim, Dong-Yun Lee & DooSeok Choi. (2019) Tissue-selective estrogen complex for women who experience breast discomfort or vaginal bleeding when on hormone therapy. Menopause 26:4, pages 383-386.
Crossref
Crossref
James H. Pickar, Matthieu Boucher & Diana Morgenstern. (2018) Tissue selective estrogen complex (TSEC): a review. Menopause 25:9, pages 1033-1045.
Crossref
Crossref
Wei Yue, Jiping Wang, Kristen A. Atkins, Lisa Bottalico, Clementina Mesaros, Ian A. Blair & Richard J. Santen. (2018) Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen. International Journal of Cancer 143:5, pages 1259-1268.
Crossref
Crossref
James H. Pickar, Joanne LavenbergKaijie PanBarry S. Komm. (2018) Initial investigation into the optimal dose ratio of conjugated estrogens and bazedoxifene: a double-blind, randomized, placebo-controlled phase 2 dose-finding study. Menopause 25:3, pages 273-285.
Crossref
Crossref
Malahat Khalili, Ali Hosseinzadeh, Habib_ollah Mohammadi Kiavandani & Narges Khanjani. (2018) Effects of Bazedoxifene on Bone Mineral Density and Fracture in Post-Menopausal Osteoporotic Women: a Systematic Review and Meta-Analysis. Clinical Reviews in Bone and Mineral Metabolism 16:1, pages 22-32.
Crossref
Crossref
Kathryn I. Marko & James A. Simon. (2018) Clinical trials in menopause. Menopause 25:2, pages 217-230.
Crossref
Crossref
Sung Wook Chun. (2017) An Overview of the Clinical Efficacy and Safety of Tissue Selective Estrogen Complex: From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials. Kosin Medical Journal 32:1, pages 5-16.
Crossref
Crossref
Santiago Palacios & Mariella Lilue. 2017. Menopause. Menopause
197
212
.
Michael F. Holick. 2017. Essentials of Menopause Management. Essentials of Menopause Management
145
164
.
Raja Sayegh & Johnny T. Awwad. 2017. Essentials of Menopause Management. Essentials of Menopause Management
13
43
.
Lucy Abraham, Andrew G. Bushmakin, Erika Dragon, Barry S. Komm & JoAnn V. Pinkerton. (2016) Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women. Maturitas 94, pages 173-179.
Crossref
Crossref
Risa Kagan, Barry S. Komm, Kelly A. Ryan, Joanne Lavenberg, Ching-Ray Yu & JoAnn V. Pinkerton. (2016) Timing and persistence of effect of conjugated estrogens/bazedoxifene in postmenopausal women. Menopause 23:11, pages 1204-1213.
Crossref
Crossref
David F. ArcherEllen W. FreemanBarry S. KommKelly A. RyanChing-Ray YuSebastian MirkinJoAnn V. Pinkerton. (2016) Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials. Journal of Women's Health 25:11, pages 1102-1111.
Crossref
Crossref
Clare A. Flannery, Andrew G. Fleming, Gina H. Choe, Hanyia Naqvi, Margaret Zhang, Anu Sharma & Hugh S. Taylor. (2016) Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium. Endocrinology 157:10, pages 3699-3708.
Crossref
Crossref
J. Christopher Gallagher, Santiago Palacios, Kelly A. Ryan, Ching-Ray Yu, Kaijie Pan, David L. KendlerSebastian Mirkin & Barry S. Komm. (2016) Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials. Menopause 23:10, pages 1083-1091.
Crossref
Crossref
JoAnn V. Pinkerton, James H. Pickar, Kelly A. Ryan, Ching-Ray YuSebastian Mirkin & Barry S. Komm. (2016) Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials. Menopause 23:6, pages 611-620.
Crossref
Crossref
Sebastian MirkinJoAnn V. PinkertonRisa KaganJohn R. ThompsonKaijie PanJames H. PickarBarry S. KommDavid F. Archer. (2016) Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials. Journal of Women's Health 25:5, pages 431-442.
Crossref
Crossref
Elena M. Umland, Lauren Karel & Nanette Santoro. (2016) Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:5, pages 548-561.
Crossref
Crossref
Denise Black, Michael Messig, Ching-Ray Yu, Annlouise R. Assaf, Barry S. Komm, Sebastian Mirkin & Matthieu Boucher. (2016) The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women. Menopause 23:4, pages 376-382.
Crossref
Crossref
James H Pickar & Barry S Komm. (2015) Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast. Post Reproductive Health 21:3, pages 112-121.
Crossref
Crossref
Sven O. Skouby, Kaijie Pan, John R. Thompson, Barry S. Komm & Sebastian Mirkin. (2015) Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables. Menopause 22:6, pages 640-649.
Crossref
Crossref
Petra Stute & Martin Birkhäuser. (2015) Selektive Östrogenrezeptormodulatoren (SERM)Selective estrogen receptor modulators (SERM). Gynäkologische Endokrinologie 13:2, pages 126-134.
Crossref
Crossref
Santiago Palacios, Heather Currie, Tomi S. Mikkola & Erika Dragon. (2015) Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: A practical guide. Maturitas 80:4, pages 435-440.
Crossref
Crossref
Sebastian Mirkin, David F. Archer, James H. Pickar & Barry S. Komm. (2015) Recent advances help understand and improve the safety of menopausal therapies. Menopause 22:3, pages 351-360.
Crossref
Crossref
Lucy Abraham, Louise Humphrey, Rob Arbuckle, Lorraine Dennerstein, James A. Simon, Sebastian Mirkin, Nicola Bonner, Steven Walmsley, Sophi Tatlock & Tara Symonds. (2015) Qualitative cross-cultural exploration of breast symptoms and impacts associated with hormonal treatments for menopausal symptoms to inform the development of new patient-reported measurement tools. Maturitas 80:3, pages 273-281.
Crossref
Crossref
J.Y. Reginster, A. Neuprez, N. Dardenne, C. Beaudart, P. Emonts & O. Bruyere. (2014) Efficacy and safety of currently marketed anti-osteoporosis medications. Best Practice & Research Clinical Endocrinology & Metabolism 28:6, pages 809-834.
Crossref
Crossref
Barry S. Komm, Sebastian Mirkin & Simon N. Jenkins. (2014) Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss. Steroids 90, pages 71-81.
Crossref
Crossref
Ping Fan & V. Craig Jordan. (2014) Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations. Steroids 90, pages 44-52.
Crossref
Crossref
F. Cosman, S. J. de Beur, M. S. LeBoff, E. M. Lewiecki, B. Tanner, S. Randall & R. Lindsay. (2014) Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis International 25:10, pages 2359-2381.
Crossref
Crossref
Lucy Abraham, JoAnn V. Pinkerton, Michael Messig, Kelly A. Ryan, Barry S. Komm & Sebastian Mirkin. (2014) Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene. Maturitas 78:3, pages 212-218.
Crossref
Crossref
JoAnn V. Pinkerton & Semara Thomas. (2014) Use of SERMs for treatment in postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology 142, pages 142-154.
Crossref
Crossref
Carolyn L Smith, Richard J Santen, Barry Komm & Sebastian Mirkin. (2014) Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes. Breast Cancer Research 16:3.
Crossref
Crossref
Sebastian Mirkin, Kelly A. Ryan, Arthi B. Chandran & Barry S. Komm. (2014) Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms. Maturitas 77:1, pages 24-31.
Crossref
Crossref